+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018

  • ID: 4663486
  • Clinical Trials
  • September 2018
  • Region: Global
  • 1094 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Adocia SAS
  • AstraZeneca Plc
  • Eli Lilly and Co
  • MannKind Corp
  • Pfizer Inc
  • ProSciento Inc
  • MORE
Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018

Summary

This clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario. This report provides top line data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary databases - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adocia SAS
  • AstraZeneca Plc
  • Eli Lilly and Co
  • MannKind Corp
  • Pfizer Inc
  • ProSciento Inc
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Type 1 Diabetes (Juvenile Diabetes)
Jul 18, 2018: Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus
Jul 04, 2018: The GABA/Diamyd trial in the US now fully recruited
Jun 25, 2018: Additional Positive Afrezza Clinical Data from STAT Study to Be Presented at ADA 78th Scientific Sessions
Jun 25, 2018: Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
Jun 25, 2018: FARXIGA in Combination with ONGLYZA Demonstrates Similar Glycemic Control with Additional Benefits vs. Insulin Glargine in Patients with Type 2 Diabetes
Jun 25, 2018: Xeris Pharmaceuticals Announces Positive Phase 3 Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen
Jun 24, 2018: Adding Liraglutide to Insulin Regimen for People with Type 1 Diabetes Improved Glycemic Control
Jun 24, 2018: Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type Type 1 Diabetes
Jun 24, 2018: Dapagliflozin as Adjunct Therapy to Insulin for People with Type 1 Diabetes May Improve Glycemic Control
Jun 24, 2018: Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care
Jun 23, 2018: Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care
Jun 23, 2018: New Data Presented at the American Diabetes Association 78th Scientific Sessions Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes
Jun 23, 2018: Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas
Jun 23, 2018: MannKind Presents Positive Afrezza Clinical Data from STAT and AFFINITY Studies at ADA 78th Scientific Sessions
Jun 22, 2018: vTv Therapeutics to Present a Poster at the American Diabetes Association’s 78th Scientific Sessions
Jun 21, 2018: Oramed Initiates Food Effect Study for Its Oral Insulin Capsule ORMD-0801
Jun 18, 2018: Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
Contact Us
Source

List of Tables
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*

List of Figures
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lilly and Co
  • Sanofi
  • Pfizer Inc
  • ProSciento Inc
  • AstraZeneca Plc
  • Adocia SAS
  • MannKind Corp
  • C. H. Boehringer Sohn AG & Co KG
  • Steno Diabetes Center Copenhagen
  • Lexicon Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll